Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables (2016 - 2019)

Sunshine Biopharma's Change in Account Payables history spans 8 years, with the latest figure at $33797.0 for Q4 2019.

  • For Q4 2019, Change in Account Payables fell 49.57% year-over-year to $33797.0; the TTM value through Dec 2019 reached -$18692.0, down 130.33%, while the annual FY2020 figure was -$35012.0, 87.31% down from the prior year.
  • Change in Account Payables reached $33797.0 in Q4 2019 per SBFM's latest filing, up from -$21040.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $342944.0 in Q2 2017 to a low of -$359099.0 in Q3 2017.
  • Average Change in Account Payables over 5 years is -$1484.3, with a median of -$122.0 recorded in 2018.
  • Peak YoY movement for Change in Account Payables: crashed 6587.13% in 2018, then soared 18113.93% in 2019.
  • A 5-year view of Change in Account Payables shows it stood at $11830.0 in 2015, then surged by 134.99% to $27799.0 in 2016, then crashed by 41.27% to $16326.0 in 2017, then surged by 310.51% to $67020.0 in 2018, then tumbled by 49.57% to $33797.0 in 2019.
  • Per Business Quant, the three most recent readings for SBFM's Change in Account Payables are $33797.0 (Q4 2019), -$21040.0 (Q3 2019), and $21977.0 (Q2 2019).